OBI Pharma Announces Poster Presentations at AACR 2023 Annual Meeting for OBI-999 combination synergy with checkpoint inhibitor as well as Globo H-targeted CAR T-cell immunotherapy
Globo Farmacêutica
Globo Pharma ABRE NOVAS VAGAS em SP e MG - Brasil123